ARCHIVES

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

When Is A Cancer Cured? NCI Suggest One-Year Survival Rates Useful In Determining Advances

August 1, 1975

Amgen Website Invites Testimonials, Posts Off-Label Claims By Patients.

November 9, 2007

New Therapeutic Options Enhance Breast Cancer Treatment: ASCO Reports

July 26, 2002

Experts Call For Large International Study Of Mammography Screening In Ages 40-42

October 15, 1993

Calif. Stem Cell Group To Collaborate With Canadians.

June 20, 2008

Gramm-Rudman Cut Facing NCI Could Take $85 Million

October 20, 1989